Key result
A review of 16 case reports, 2 longitudinal studies, and 3 clinical trials found that edetate sodium (EDTA) chelation therapy is ineffective for treating atherosclerosis.
Why the study?
Does edetate sodium chelation therapy improve outcomes in patients with atherosclerosis?
Population
Patients with atherosclerosis
Design
Systematic_review
Authors
Loading...
EDTA chelation should not be used for atherosclerosis; confirms lack of efficacy across reviewed trials and studies.
Does edetate sodium chelation therapy improve outcomes in patients with atherosclerosis?
EDTA chelation therapy lacks valid scientific evidence for efficacy and should not be used in clinical practice to treat atherosclerosis.
Grier et al. (1993) conducted a review in atherosclerosis. edetate sodium (EDTA) chelation therapy was evaluated on safety and efficacy. A review of 16 case reports, 2 longitudinal studies, and 3 clinical trials found that edetate sodium (EDTA) chelation therapy is ineffective for treating atherosclerosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: